Sinovac Director: We May Have Covid-19 Vaccine Phase III Trial Results by December

The results follow news this month from Pfizer and BioNTech and from Moderna, as well as from Russia, of experimental vaccines proving more than 90% effective, based on interim data from large, late-stage trials.

RIO DE JANEIRO, BRAZIL - Chinese vaccine maker Sinovac Biotech could have the results of its experimental COVID-19 vaccine from late-stage clinical trials as soon as next month, an executive said on Friday, November 20th.

Sinovac’s CoronaVac is in large late-stage trials in Brazil, Indonesia and Turkey. Preliminary results of early to mid-stage trials showed this week that it triggered a quick immune response but lower levels of antibodies than those seen in people who have recovered from COVID-19.

“Phase III is now running quite well,” Weining Meng, senior director of Sinovac, told the Global . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?